Michelle Sholzberg


Scientist, Keenan Research Centre for Biomedical Science (KRCBS)


Dr. Michelle Sholzberg received her MDCM and residency training in Internal Medicine at McGill University, completed additional postgraduate training in Hematology at the University of Toronto and a research hemostasis fellowship in Toronto and internationally. Dr. Sholzberg has a Master of Science from the University of Toronto in Clinical Epidemiology and Health Care Research and was awarded the Claire Bombardier award for career promise as a scientist. She is a clinician-scientist with a focus on coagulation, the Division Head of Hematology-Oncology and the Medical Director of the Coagulation Laboratory at St. Michael’s Hospital. She is also the Director of the Hematology-Oncology Clinical Research Group and Co-director of the Hematology-Immunology Translational Research Theme of the Li Ka Shing Knowledge Institute. Currently, she is involved in the study of: prediction tools for perioperative and traumatic bleeding, the intersection of women’s health and bleeding disorders, treatments for iron deficiency anemia, new treatments for immune thrombocytopenia and the management of COVID-19 coagulopathy.

Recent Publications

  1. Gil Gonzalez, L, Won, KD, Tawhidi, Z, Cummins, E, Cruz-Leal, Y, Tundidor, Y et al.. Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized-murine model of ITP. Blood Adv. 2024; :. doi: 10.1182/bloodadvances.2023012155. PubMed PMID:38330193 .
  2. Manuel, P, Tang, GH, Weyand, A, James, P, Sholzberg, M. Academic bullying in science and medicine: the need for reform. Res Pract Thromb Haemost. 2024;8 (1):102270. doi: 10.1016/j.rpth.2023.102270. PubMed PMID:38222079 PubMed Central PMC10784303.
  3. Tang, GH, Sholzberg, M. Iron deficiency anemia among women: An issue of health equity. Blood Rev. 2023; :101159. doi: 10.1016/j.blre.2023.101159. PubMed PMID:38042684 .
  4. Richard, ES, Hrycyshyn, A, Salman, N, Remtulla Tharani, A, Abbruzzino, A, Smith, J et al.. Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician Survey. Curr Oncol. 2023;30 (11):9836-9848. doi: 10.3390/curroncol30110714. PubMed PMID:37999134 PubMed Central PMC10670404.
  5. Thachil, J, Connors, JM, Mahlangu, J, Sholzberg, M. "Reclassifying hemophilia to include the definition of outcomes and phenotype as new targets": Reply. J Thromb Haemost. 2023;21 (10):2980-2981. doi: 10.1016/j.jtha.2023.07.029. PubMed PMID:37739593 .
  6. Tang, GH, Thachil, J, Bowman, M, Bekdache, C, James, PD, Sholzberg, M et al.. Patient-centered care in von Willebrand disease: are we there yet?. Expert Rev Hematol. 2023;16 (9):641-649. doi: 10.1080/17474086.2023.2243386. PubMed PMID:37581602 .
  7. Kahn, SR, Arnold, DM, Casari, C, Desch, KC, Devreese, KMJ, Favaloro, EJ et al.. Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress. Res Pract Thromb Haemost. 2023;7 (4):100193. doi: 10.1016/j.rpth.2023.100193. PubMed PMID:37538494 PubMed Central PMC10394567.
  8. MacLean, B, Sholzberg, M, Weyand, AC, Lim, J, Tang, G, Richards, T et al.. Identification of women and girls with iron deficiency in the reproductive years. Int J Gynaecol Obstet. 2023;162 Suppl 2 :58-67. doi: 10.1002/ijgo.14948. PubMed PMID:37538015 .
  9. Gomez Builes, JC, Baker, AJ, Callum, J, Barahi, S, Bai, J, Karkouti, K et al.. Evaluation of the association of factor XIII at hospital arrival and outcomes in a cohort of severely injured patients. J Thromb Haemost. 2023;21 (11):3085-3098. doi: 10.1016/j.jtha.2023.07.002. PubMed PMID:37453456 .
  10. Weyand, AC, Chaitoff, A, Freed, GL, Sholzberg, M, Choi, SW, McGann, PT et al.. Prevalence of Iron Deficiency and Iron-Deficiency Anemia in US Females Aged 12-21 Years, 2003-2020. JAMA. 2023;329 (24):2191-2193. doi: 10.1001/jama.2023.8020. PubMed PMID:37367984 PubMed Central PMC10300696.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Division of Hematology, St. Michael’s Hospital
  • Assistant Professor, Department of Medicine, University of Toronto